Article

Growth hormone therapy in Turner syndrome

Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7032, USA.
Pediatric endocrinology reviews: PER 05/2012; 9 Suppl 2(Suppl 2):723-4.
Source: PubMed

ABSTRACT Short stature is the single most common physical abnormality in Turner syndrome (TS) with adult stature averaging 20 cm shorter than that of the general population. Randomized, placebo-controlled studies to final adult height have proven that GH therapy is effective in increasing stature in TS. Recently, randomized, controlled studies have demonstrated that adjunctive therapies with low-dose estrogen or low-dose oxandrolone enhance stature further. These therapies may provide benefits beyond height augmentation.

3 Followers
 · 
176 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Testosterone (T) drives normal male sexual development both in utero and at puberty. Aberrant T exposure manifests as virilization of a female fetus, contrasexual precocity in girls, and isosexual precocity in boys. Evidence of pathologic T exposure warrants a prompt evaluation. Areas covered: The authors introduce the topic of T exposure in children by reviewing its physiology in the fetus and during childhood and adolescence. Pathologic conditions leading to virilization of a female fetus as well as androgen-mediated gonadotropin-independent precocious puberty in both genders are then discussed. The authors finish by noting exogenous T exposure in children and adolescents, focusing specifically on secondary exposure to topical T preparations. Expert opinion: Contrasexual precocity in a girl or sexual precocity in a boy should prompt evaluation for causes of gonadotropin-independent pubertal changes. Initial biochemical evaluation includes a bone age, T, 17-hydroxyprogesterone, androstenedione, dehydroepiandrosterone sulfate (DHEA-S) and high sensitivity gonadotropin levels. The provider must query exposure to topical androgen-containing preparations as unintentional secondary exposure to topical T must be considered. Hyperandrogenism is temporally related to exposure of topical T and removal of exposure results in a marked decrease in serum T as well as resolution or stabilization of the signs and symptoms.
    Expert Opinion on Drug Safety 03/2013; DOI:10.1517/14740338.2013.782000 · 2.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Morbus Kawasaki je akutna bolest dječje dobi u osnovi koje je vaskulitis s predilekcijom za koronarne arterije. Etiologija bolesti je nepoznata. Najčešće obole djeca mlađa od 4 godine. Bolest se razvija u tri faze (akutna, subakutna, rekovalescentna) koje su karakterizirane jedinstvenim znacima i simptomima. Jedino su klinički znaci akutne faze značajni za postavljanje dijagnoze: temperatura ≥ pet dana uz postojanje četiri od sljedećih pet znakova: eritem i otok šaka i stopala, polimorfni osip, bilateralni konjuktivitis, promjene usnica i usne šupljine, cervikalna limfadenopatija. Kod pacijenta s povišenom temperaturom trajanja > pet dana i manje od četiri znaka akutne faze dijagnoza se može postaviti ako se ehokardiografski utvrdi abnormalnost koronarnih arterija. Osim kardiovaskularnog, u akutnoj fazi bolest može zahvatiti muskuloskeletni, genitourinarni, gastrointestinalni i središnji živčani sustav. Zahvaćenost hepatobilijarnog sustava javlja se u 40%, a hidrops žučnog mjehura u 10% slučajeva, dok je zahvaćenost gušterače u akutnoj fazi rijetka. Osim kliničkih, u akutnoj fazi bolesti nastaju i nespecifi čne promjene u laboratorijskim nalazima te čine značajnu potporu kod postavljanja dijagnoze. U subakutnoj fazi tipično je ljuštenje kože periungvalno te na vrhovima prstiju šaka i stopala. Ehokardiografski vide se promjene koronarnih arterija. U liječenju bolesti primjenjuju se humani IVIG i aspirin. Primjena IVIG-a za prvih sedam, odnosno 10 dana bolesti značajno prevenira abnormalnosti koronarnih arterija. U ovom radu prikazujemo trogodišnju djevojčicu kod koje je uz kliničke i laboratorijske znakove akutne upale gušterače i hepatobilijarnog trakta te ultrasonografski prikaz hidropsa žučnog mjehura i ektazija koronarnih arterija postavljena dijagnoza Mb. Kawasaki u petom danu bolesti. Liječena je jednokratno visokom dozom humanog IVIG-a, protuupalnom dozom acetilsalicilne kiseline, klopidrogrelom, uz primjenu esomeprazola te pankreatičnudijetu. Nastanak tipičnog ljuštenja vrhova prstiju na rukama u subakutnoj fazi bolesti kao i pojava transverzalnih žljebova na noktima prstiju u rekovalescentnoj fazi potvrdilo je dijagnozu. Ehokardiografski nisu utvrđene abnormalnosti koronarnih arterija u subakutnoj i rekovalescentnoj fazi. Cilj ovog rada je uputiti na to da kod akutno febrilnog djeteta i naizgled atipične kliničke slike treba misliti na rijetke uzroke bolesti kao što je Mb. Kawasaki te da se pravodobnim i odgovarajućim liječenjem mogu spriječiti abnormalnosti koronarnih arterija.
    11th Congress of Croatian Pediatric Society with international participation, Dubrovnik 16.-19. october 2014., Dubrovnik; 01/2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Girls and women with Turner's syndrome who come to medical attention older than 12 years present a challenge of medical management. Puberty is already delayed and some compromises have to be made in adjusting the timing of artificially induced puberty to optimise overall outcome with respect to stature, secondary sex characteristics, and psychosocial endpoints. Additionally, individuals who present with primary amenorrhoea to adult services might miss the opportunity for effective growth hormone treatment. Further, induction of puberty regimens lack an evidence base or even clear guidelines for the timing and dose of oestrogen replacement. We have searched the scientific literature to inform management of Turner's syndrome.
    04/2014; 2(4):333-338. DOI:10.1016/S2213-8587(13)70153-0
Show more